Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab

A 69-year-old man with stage III lung squamous cell carcinoma developed immune-related hepatitis following treatment with durvalumab, and was given high-dose corticosteroids and immunosuppressive drugs (mycophenolate mofetil, azathioprine, tacrolimus) but without demonstrating any improvement. Two c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Intern Med
Hlavní autoři: Nakashima, Koki, Demura, Yoshiki, Oi, Masahiro, Tabata, Mio, Tada, Toshihiko, Shiozaki, Kohei, Akai, Masaya, Ishizuka, Tamotsu
Médium: Artigo
Jazyk:Inglês
Vydáno: The Japanese Society of Internal Medicine 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7759708/
https://ncbi.nlm.nih.gov/pubmed/32727989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5216-20
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky